Kansikuva näyttelystä The Big4Bio Podcast

The Big4Bio Podcast

Podcast by Big4Bio

englanti

Teknologia & tieteet

Sitten 7,99 € / kuukausi. Peru milloin tahansa.

  • Podimon podcastit
  • Lataa offline-käyttöön

Lisää The Big4Bio Podcast

The Big4Bio Podcast shares podcasts that give insight and information about/from biotech and life science leaders and organizations within the Big4Bio regions. Check out our Playlists to hear podcasts by region.

Kaikki jaksot

56 jaksot

jakson Every Moment Matters: Developing an N-of-1 ASO for a Child with an Ultra-Rare Disease kansikuva

Every Moment Matters: Developing an N-of-1 ASO for a Child with an Ultra-Rare Disease

Advances in sequencing, the emergence of antisense oligonucleotide therapies, and the advent of induced pluripotent stem cell technology are among the combination of factors that have made bespoke medicines for individual patients scientifically feasible. In the case of ultra-rare, genetic diseases, a child may face a progressive, life-threatening condition with no available treatments. As we continue our series on discovery with Charles River Laboratories, we take a look at how the organization partnered with global collaborators and a patient’s family to design, screen, and advance a highly selective antisense oligonucleotide therapy targeting a pathogenic allele underlying a child’s ultra-rare epileptic encephalopathy. We spoke to Charles River Lab’s Associate Research Leader Blanca Torroba and Group Leader of Neuropharmacology Johanna Uhari Väänänen about how they moved from concept to a candidate for a custom ASO therapy, steps they took to accelerate the process, and the challenges of advancing N of 1 medicines to an IND.nbRb

25. helmi 2026 - 40 min
jakson Every Moment Matters: The Power of Study Director–Advisor Partnerships kansikuva

Every Moment Matters: The Power of Study Director–Advisor Partnerships

At Charles River Laboratories, scientific advisors and study directors have complementary roles in nonclinical drug development. Scientific advisors bring years of scientific and regulatory experience to program-level strategy, while study directors act as operational captains who execute individual studies under good laboratory practice. Close collaboration between the two plays a critical role in helping clients build coherent, IND-enabling safety packages. We spoke to Pramila Singh, senior principal scientific advisor at Charles River Laboratories, about how scientific advisor–study director collaborations are crucial for creating robust, regulatory-ready study designs, how they help prevent costly errors, and how they can accelerate development timelines.

4. helmi 2026 - 26 min
jakson Every Moment Matters: Getting Better Insights on Target and off Target Biology kansikuva

Every Moment Matters: Getting Better Insights on Target and off Target Biology

Biologic drug development increasingly relies on sensitive, human relevant platforms capable of detecting both intended and unintended target engagement well before first in human studies. Charles River Laboratories is leveraging its Retrogenix cell microarray platform alongside traditional tissue cross-reactivity studies to gain a more comprehensive view of target and off-target biology. We spoke with Charles River Labs Associate Director of Advanced Modalities Mark Aspinall O’Dea and Charles River Labs Senior Scientific Director James Raymond, about how combining these two approaches helps sponsors select better leads, design safer studies, and meet regulatory expectations for complex modalities.

21. tammi 2026 - 29 min
jakson Every Moment Matters: How Integrated Teams De-Risk the Path from Discovery to IND kansikuva

Every Moment Matters: How Integrated Teams De-Risk the Path from Discovery to IND

The journey from discovery to IND is rarely linear. It demands rigorous target validation, continuous regulatory engagement, and the use of translationally relevant models to effectively de risk programs before they advance. In this installment of Big4Bio’s ongoing series with Charles River Laboratories, we look at how the company’s One Step approach guides sponsors from discovery concept to IND-ready clinical candidate. We spoke to Manu Kohli, principal scientific advisor for Charles River Labs, about how the company’s integrated development model works, the benefits of having an end-to-end drug development solution under one roof, and how this approach helps deliver submission-ready assets on time and on budget.

14. tammi 2026 - 40 min
Loistava design ja vihdoin on helppo löytää podcasteja, joista oikeasti tykkää
Loistava design ja vihdoin on helppo löytää podcasteja, joista oikeasti tykkää
Kiva sovellus podcastien kuunteluun, ja sisältö on monipuolista ja kiinnostavaa
Todella kiva äppi, helppo käyttää ja paljon podcasteja, joita en tiennyt ennestään.

Valitse tilauksesi

Suosituimmat

Rajoitettu tarjous

Premium

  • Podimon podcastit

  • Ei mainoksia Podimon podcasteissa

  • Peru milloin tahansa

3 kuukautta hintaan 7,99 €
Sitten 7,99 € / kuukausi

Aloita nyt

Premium

20 tuntia äänikirjoja

  • Podimon podcastit

  • Ei mainoksia Podimon podcasteissa

  • Peru milloin tahansa

30 vrk ilmainen kokeilu
Sitten 9,99 € / kuukausi

Aloita maksutta

Premium

100 tuntia äänikirjoja

  • Podimon podcastit

  • Ei mainoksia Podimon podcasteissa

  • Peru milloin tahansa

30 vrk ilmainen kokeilu
Sitten 19,99 € / kuukausi

Aloita maksutta

Vain Podimossa

Suosittuja äänikirjoja

Usein kysytyt kysymykset

Lisää kysymyksiä & vastauksia
Aloita nyt

3 kuukautta hintaan 7,99 €. Sitten 7,99 € / kuukausi. Peru milloin tahansa.